NCT04452162
- Conditions
- Head and Neck Neoplasms, Mouth Diseases, Mouth Neoplasms, +6 more
- Locations
-
- Hospital of the University of Pennsylvania Philadelphia, Pennsylvania, United States
Clinical trial condition
Salivary Gland Neoplasms
Explore clinical trials studying Salivary Gland Neoplasms. Study availability and eligibility vary by location and protocol.
191 public trials
24 recruiting studies
Salivary Gland Neoplasms trial results
Recruiting
A Phase 2 Trial of Ivonescimab for Patients With Advanced, Metastatic Salivary Gland Cancers
NCT06805617
- Conditions
- Adenocarcinoma, Adenoid Cystic Carcinoma, Advanced Salivary Gland Carcinoma, +14 more
- Locations
-
- Brigham and Women's Hospital Boston, Massachusetts, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
NCT06923826
- Conditions
- Endocrine Gland Neoplasms, Endocrine System Diseases, Head and Neck Neoplasms, +11 more
- Locations
-
- National University Cancer Institute Singapore Singapore
NCT04214366
- Conditions
- Adenocarcinoma, Adenoid Cystic Carcinoma, Carcinoma, +11 more
- Locations
-
- University of Heidelberg, Radiooncology, HIT Heidelberg, Germany
Not yet recruiting
Docetaxel and SX-682 in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma, Salivary Gland Carcinoma, and Advanced Prostate Cancer
NCT07667400
- Conditions
- Adenocarcinoma, Adenoid Cystic Carcinoma, Carcinoma, +46 more
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
Not yet recruiting
Gene Expression Profiling in a Validation Cohort of Locally Advanced and Recurrent/Metastatic Salivary Gland Cancers
NCT06091878
- Conditions
- Head and Neck Neoplasms, Mouth Diseases, Mouth Neoplasms, +6 more
- Locations
-
Not specified
Not yet recruiting
Neratinib Tablets Monotherapy for Advanced Solid Tumors With HER2 Mutations
NCT06519110
- Conditions
- Adenocarcinoma, Advanced Solid Tumor, Bronchial Neoplasms, +30 more
- Locations
-
Not specified
Active, not recruiting
A Study of Apalutamide Combined With GnRH Agonist in Participants With Androgen Receptor Positive Salivary Gland Carcinoma
NCT04325828
- Conditions
- Head and Neck Neoplasms, Mouth Diseases, Mouth Neoplasms, +5 more
- Locations
-
- National Cancer Center Hospital Chūōku, Japan
- National Hospital Organization Kyushu Medical Center Fukuoka, Japan
- Kansai Medical University Hospital Hirakata, Japan
- National Hospital Organization Shikoku Cancer Center Matsuyama, Japan
Active, not recruiting
Study Of Entrectinib (Rxdx-101) in Children and Adolescents With Locally Advanced Or Metastatic Solid Or Primary CNS Tumors And/Or Who Have No Satisfactory Treatment Options
NCT02650401
- Conditions
- Adenocarcinoma, Adenocarcinoma, Papillary, Brain Diseases, +59 more
- Locations
-
- University of California San Diego La Jolla, California, United States
- UCSF Benioff Children's Hospital San Francisco, California, United States
- Children's Hospital Colorado Aurora, Colorado, United States
- Egleston Children's Hospital at Emory University Atlanta Atlanta, Georgia, United States
Active, not recruiting
Safety, PK and Efficacy of ONC-392 in Monotherapy and in Combination of Anti-PD-1 in Advanced Solid Tumors and NSCLC
NCT04140526
- Conditions
- Adenocarcinoma, Adenoid Cystic Carcinoma, Adnexal Diseases, +94 more
- Locations
-
- Highlands Oncology Group Springdale, Arkansas, United States
- University of California at Davis Davis, California, United States
- The Oncology Institute of Hope and Innovation Downey, California, United States
- City of Hope Cancer Center Duarte, California, United States